Adage Capital Partners
NERV icon

Adage Capital Partners’s Minerva Neurosciences NERV Stock Holding History

Adage Capital Partners’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.55M Sell
1,419,000
-1,419,000
-50% -$8.14M 0.01% 724
2025
Q4 		$11.4M Buy
+2,838,000
New +$10.5M 0.02% 639

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM

Adage Capital Partners's NERV Position: Q1 2026 in Review

Adage Capital Partners reduced its Minerva Neurosciences (NERV) stake by 50% in Q1 2026, selling an estimated $8.14M and leaving 1,419,000 shares worth $8.55M. The position accounts for 0.01% of the portfolio, ranked #724.

Adage Capital Partners first reported a position in NERV in Q4 2025 and has held it in 2 quarters since. The position peaked at $11.4M in Q4 2025. 47 funds tracked by Wall St. Rank hold NERV as of Q1 2026.

  • Adage Capital Partners held 1,419,000 shares of Minerva Neurosciences worth $8.55M as of Q1 2026.
  • Adage Capital Partners sold 1,419,000 Minerva Neurosciences shares in Q1 2026, an estimated $8.14M.
  • Minerva Neurosciences made up 0.01% of Adage Capital Partners's portfolio in Q1 2026, its #724 holding.
  • Adage Capital Partners first reported a position in Minerva Neurosciences in Q4 2025 and has held it in 2 quarters since.
  • Adage Capital Partners's Minerva Neurosciences position peaked at $11.4M in Q4 2025.
  • 47 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q1 2026.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.